Studienserver - Medizinische Hochschule Hannover

Studies: Everolimus for patients with relapsed/refractory germ cell cancer (RADIT)

ID Trial

CRAD001CDE21T

Local trial identifier

KS-2009-002

EudraCT number

2009-014383-18

Clinicaltrials.gov identifier

NCT01242631

Description

A single arm, open-label multicenter phase II trial of RAD001 in patients with relapsed/refractory germ cell cancer

Status

active